CCAAT/enhancer‐binding protein delta (C/EBPδ) has been shown to promote tumour growth, drug resistance and metastasis formation in some cancers, whereas we have shown that its re‐expression limits the features of tumour progression in pancreatic ductal adenocarcinoma (PDAC). Here, CEBPD is linked to neoplasm.